| Pfizer AG - Adriblastin RD 50 mg, Pulver zur Herstellung einer Injektionslösung |
| 50357 | | 03 | | Adriblastin RD 50 mg | | Pulver zur Herstellung einer Injektionslösung | | L01DB01 | | Doxorubicin | | 27.10.1989 | | |
|
| Composition |
| Praeparatio cryodesiccata: doxorubicini hydrochloridum 50 mg, lactosum monohydricum, E 218 5 mg pro vitro. |
| Packungsbestandteile |
| Praeparatio cryodesiccata: | | | Injection preparation | | | | | | | | Active Agent | Dose |
|---|
| Doxorubicin Hydrochloride | 50 mg |
| | BAG: Active Agent | Dose |
|---|
| Doxorubicin Hydrochloride | 50 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| E 218 | 5 mg | conserv. | | Lactose Monohydrate | | |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | | 73.00 | 94.70 | A | SL | Yes |
|
